HealthRX review

HealthRX offers two compounded GLP-1 injections. The product pages checked October 6 show a $149 first month followed by $165 monthly for semaglutide, and $193 followed by $214 for tirzepatide under Subscribe & Save. This corrects older parts of our review that described an oral GLP-1 tablet and an available branded Ozempic plan; the reviewed weight-loss catalog does not support those descriptions.

The product tables offer longer commitments: semaglutide shows $374, $689 and $1,163 for the three-, six- and twelve-month plans, while tirzepatide shows $602, $1,169 and $2,123. Those amounts differ from the separate pricing page, which still labels its figures July 28. Use the final checkout charge as the point to verify; a headline monthly equivalent alone is insufficient.

There is also a supply question. The monthly plan describes four weeks of medication, and the longest plan describes 48 weeks, while the next charges are expressed in calendar months. Ask how refills cover the interval before renewal and whether any additional prescription or charge is required. Do not assume a plan labeled twelve months automatically supplies 52 weeks.

The pages list provider review, medication if prescribed, instructions, shipping and support within the plan. They say payment precedes the medical intake and offer a full refund if a provider does not approve treatment. That ordering matters if you prefer a clinical decision before a charge.

Our view is that HealthRX provides useful cost detail but needs greater consistency between its public tables. Save the selected plan terms, ask which pharmacy will dispense your prescription, and clarify the cancellation treatment of unshipped medication. A certification badge is not approval of a compounded drug and does not establish the outcome you will have.